Diagnosis, Treatment, and Prevention of Gout
... of Gout Gout is characterized by painful joint inflammation, most commonly in the first metatarsophalangeal joint, resulting from precipitation of monosodium urate crystals in a joint space. Gout is typically diagnosed using clinical criteria from the American College of Rheumatology. Diagnosis may ...
... of Gout Gout is characterized by painful joint inflammation, most commonly in the first metatarsophalangeal joint, resulting from precipitation of monosodium urate crystals in a joint space. Gout is typically diagnosed using clinical criteria from the American College of Rheumatology. Diagnosis may ...
A review of national guidelines for management of COPD in Europe
... MANAGEMENT OF COPD | M. MIRAVITLLES ET AL. ...
... MANAGEMENT OF COPD | M. MIRAVITLLES ET AL. ...
Practice Parameter: Pharmacological treatment of migraine
... Appropriate treatment for children and adolescents with migraine requires an individually tailored strategy giving due consideration to both pharmacologic and nonpharmacologic measures in the context of the degree of disability produced by the headache. Not all children require pharmacologic interve ...
... Appropriate treatment for children and adolescents with migraine requires an individually tailored strategy giving due consideration to both pharmacologic and nonpharmacologic measures in the context of the degree of disability produced by the headache. Not all children require pharmacologic interve ...
arnuity ellipta
... occurred in patients with asthma during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids. After withdrawal from systemic corticosteroids, a number of months are required for recovery of hypothalamic-pituitary-adrenal (HPA) function. Patients who ...
... occurred in patients with asthma during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids. After withdrawal from systemic corticosteroids, a number of months are required for recovery of hypothalamic-pituitary-adrenal (HPA) function. Patients who ...
DDAVP Injection (desmopressin acetate)
... homozygous von Willebrand’s disease with factor VIII coagulant activity and factor VIII von Willebrand factor antigen levels less than 1%. Other patients may respond in a variable fashion depending on the type of molecular defect they have. Bleeding time and factor VIII coagulant activity, ristoceti ...
... homozygous von Willebrand’s disease with factor VIII coagulant activity and factor VIII von Willebrand factor antigen levels less than 1%. Other patients may respond in a variable fashion depending on the type of molecular defect they have. Bleeding time and factor VIII coagulant activity, ristoceti ...
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in
... contiguous with that of the paranasal sinuses, any inflammation of the sinuses is almost always accompanied by inflammation of the nasal cavity [7, 8]. Rhinosinusitis is an extremely common condition. In a national health survey conducted during 2008, nearly 1 in 7 (13.4%) of all noninstitutionalize ...
... contiguous with that of the paranasal sinuses, any inflammation of the sinuses is almost always accompanied by inflammation of the nasal cavity [7, 8]. Rhinosinusitis is an extremely common condition. In a national health survey conducted during 2008, nearly 1 in 7 (13.4%) of all noninstitutionalize ...
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
... required infusion of platelets to control hemorrhage after gingivectomy. These authors suggested that the rarity of such cases points to a considerable variability in the individual platelet response to the drug.[19] Canigral et al. conducted a research involving surgical extraction in patients on a ...
... required infusion of platelets to control hemorrhage after gingivectomy. These authors suggested that the rarity of such cases points to a considerable variability in the individual platelet response to the drug.[19] Canigral et al. conducted a research involving surgical extraction in patients on a ...
Vagus Nerve Stimulation - UnitedHealthcareOnline.com
... focal or multifocal versus generalized seizures. There was no significant difference in the mean percentage seizure reduction between patients with and without a history of IES. There was no correlation between type of failed IES (callosotomy versus resection) and seizure reduction with VNS therapy. ...
... focal or multifocal versus generalized seizures. There was no significant difference in the mean percentage seizure reduction between patients with and without a history of IES. There was no correlation between type of failed IES (callosotomy versus resection) and seizure reduction with VNS therapy. ...
European Respiratory Society Guidelines on the use of nebulizers
... clinical studies but no randomized clinical trials on the topic of recommendation (levels IIa, IIb and III). 3) Grade C requires evidence from expert committee reports or opinions and/or clinical experience of respected authorities (including opinions of the ERS Nebulizer Task Force). It indicates a ...
... clinical studies but no randomized clinical trials on the topic of recommendation (levels IIa, IIb and III). 3) Grade C requires evidence from expert committee reports or opinions and/or clinical experience of respected authorities (including opinions of the ERS Nebulizer Task Force). It indicates a ...
Endogenous Candida Endophthalmitis after Two Consecutive
... dilatation and curettage. The rate of development of ECE in patients with candidemia has been reported to range from 28% to 45%.(6) In spite of negative results of blood cultures, we presumed that the candidemia following dilatation and curettage increased the intravitreal fungal load on the basis o ...
... dilatation and curettage. The rate of development of ECE in patients with candidemia has been reported to range from 28% to 45%.(6) In spite of negative results of blood cultures, we presumed that the candidemia following dilatation and curettage increased the intravitreal fungal load on the basis o ...
Countering Side Effects of Modern Therapies with Chinese Herbs
... traditional formula Tingli Dazao Xiefei Tang (Lepidium and Jujube Combination) is listed. The two herbs that comprise the formula are described as follows: "Lepidium is bitter, cold, slippery, and sharp in nature. It opens and drains the lungs, purges fire, and expels sputum. To prevent its violent ...
... traditional formula Tingli Dazao Xiefei Tang (Lepidium and Jujube Combination) is listed. The two herbs that comprise the formula are described as follows: "Lepidium is bitter, cold, slippery, and sharp in nature. It opens and drains the lungs, purges fire, and expels sputum. To prevent its violent ...
Perspective Paul M Lantos
... a separate study 11.2% of respondents suffered chronic, widespread pain [69] . A quarter to a third of the general population www.expert-reviews.com ...
... a separate study 11.2% of respondents suffered chronic, widespread pain [69] . A quarter to a third of the general population www.expert-reviews.com ...
Achalasia
... neurogenic dysphagia include stroke (cerebral vascular accidents), amyotrophic lateral sclerosis (ALS), brain injury due to trauma or previous surgery, and local soft tissue and nerve damage due to head and neck surgery. However, many disorders of the nervous system and muscles can cause neurogenic ...
... neurogenic dysphagia include stroke (cerebral vascular accidents), amyotrophic lateral sclerosis (ALS), brain injury due to trauma or previous surgery, and local soft tissue and nerve damage due to head and neck surgery. However, many disorders of the nervous system and muscles can cause neurogenic ...
BIOMAGNETIC HEALING
... Arizona, owe their healing powers to naturally high levels of this qi, or biomagnetic energy. It should be noted that today, magnetic therapy is well established in other countries, such as Japan, China, India, Austria, and Germany. In the U.S., unfortunately, many healing techniques readily accepte ...
... Arizona, owe their healing powers to naturally high levels of this qi, or biomagnetic energy. It should be noted that today, magnetic therapy is well established in other countries, such as Japan, China, India, Austria, and Germany. In the U.S., unfortunately, many healing techniques readily accepte ...
Assessing Appropriateness of Antimicrobial
... Defined as human immunodeficiency virus infection, neutropenia, or longterm corticosteroid use. ...
... Defined as human immunodeficiency virus infection, neutropenia, or longterm corticosteroid use. ...
Management of Immune Thrombocytopenic Purpura in Adults
... including avoidance of drugs that inhibit platelet function, control of blood pressure, and other factors. Although no systematic studies have evaluated the efficacy of different regimens, there is general agreement that appropriate interventions should include the following4,5: • Intravenous immuno ...
... including avoidance of drugs that inhibit platelet function, control of blood pressure, and other factors. Although no systematic studies have evaluated the efficacy of different regimens, there is general agreement that appropriate interventions should include the following4,5: • Intravenous immuno ...
- Boehringer Ingelheim (Canada)
... treated with MIRAPEX. The patient was hospitalized with an elevated CPK (10.631 IU/L). The symptoms resolved with discontinuation of the medication. ...
... treated with MIRAPEX. The patient was hospitalized with an elevated CPK (10.631 IU/L). The symptoms resolved with discontinuation of the medication. ...
biomagnetic healing
... on earth, such as Lourdes, France, and Sedona, Arizona, owe their healing powers to naturally high levels of this qi, or biomagnetic energy. It should be noted that today, magnetic therapy is well established in other countries, such as Japan, China, India, Austria, and Germany. In the U.S., unfortu ...
... on earth, such as Lourdes, France, and Sedona, Arizona, owe their healing powers to naturally high levels of this qi, or biomagnetic energy. It should be noted that today, magnetic therapy is well established in other countries, such as Japan, China, India, Austria, and Germany. In the U.S., unfortu ...
Gene therapy for optic nerve disease
... therapy, but what is the potential application to the treatment of ocular disease in general and optic nerve diseases in particular? Gene therapy and the eye Compared to most other tissues of the body, the eye has several advantages that makes it a good candidate for gene therapy. The eye is a small ...
... therapy, but what is the potential application to the treatment of ocular disease in general and optic nerve diseases in particular? Gene therapy and the eye Compared to most other tissues of the body, the eye has several advantages that makes it a good candidate for gene therapy. The eye is a small ...
15. Autograft contamination during preparation for anterior cruciate
... time needed for the values to return to normal levels in patients with an implanted contaminated graft is not known. The primary goals of this prospective study were to evaluate the possibility of bone-patellar tendon-bone or hamstring tendon autograft contamination during preparation for anterior c ...
... time needed for the values to return to normal levels in patients with an implanted contaminated graft is not known. The primary goals of this prospective study were to evaluate the possibility of bone-patellar tendon-bone or hamstring tendon autograft contamination during preparation for anterior c ...
EAU Guidelines on Urinary Incontinence
... as a printed document (extended and short form) and as a CD-ROM from the EAU office or online from the EAU Web site (http://www.uroweb.org/guidelines/online-guidelines/). The extent and invasiveness of assessment of UI depends on severity and/or complexity of symptoms and clinical signs and is differ ...
... as a printed document (extended and short form) and as a CD-ROM from the EAU office or online from the EAU Web site (http://www.uroweb.org/guidelines/online-guidelines/). The extent and invasiveness of assessment of UI depends on severity and/or complexity of symptoms and clinical signs and is differ ...
CONTRAINDICATIONS - Silvergate Pharmaceuticals
... who require dosing via other routes of administration. Instruct patients and caregivers that the recommended dose should be taken weekly, as directed, and that mistaken daily use of the recommended dose has led to fatal toxicity [see Warnings and Precautions (5.5), Overdosage (10)]. It is important ...
... who require dosing via other routes of administration. Instruct patients and caregivers that the recommended dose should be taken weekly, as directed, and that mistaken daily use of the recommended dose has led to fatal toxicity [see Warnings and Precautions (5.5), Overdosage (10)]. It is important ...
Generalised Pustular Psoriasis
... necessary, despite delayed graft function, due to deterioration of skin disease and the above mentioned given treatment was ineffective. Whether sepsis and multiorgan failure was related to pustular psoriasis per se or to over-immunosuppression, this was not elucidated upon. A novel concept in the t ...
... necessary, despite delayed graft function, due to deterioration of skin disease and the above mentioned given treatment was ineffective. Whether sepsis and multiorgan failure was related to pustular psoriasis per se or to over-immunosuppression, this was not elucidated upon. A novel concept in the t ...
Functional Endoscopic Sinus Surgery (FESS)
... is indicated for use as a postoperative spacer to maintain an opening to the sinuses within the first 14 days postoperatively. This device is temporary and requires manual removal after 30 days, with implantation of a new device if needed. It is approved for infusion with saline, but not for use wit ...
... is indicated for use as a postoperative spacer to maintain an opening to the sinuses within the first 14 days postoperatively. This device is temporary and requires manual removal after 30 days, with implantation of a new device if needed. It is approved for infusion with saline, but not for use wit ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.